Related Experiment Videos
Direct analysis of thymic function in children with Down's syndrome.
Nicole Prada1, Milena Nasi2, Leonarda Troiano2
1Dipartimento di Biopatologia e Metodologie Biomediche, Università di Palermo, via Tukory 211, 90134 Palermo, Italy.
Immunity & Ageing : I & A
|February 18, 2005
Summary
Children with Down's syndrome (DS) have a reduced capacity to produce new T cells due to thymic dysfunction. This impairment, linked to age, suggests potential therapeutic targets like interleukins to improve immune function in DS.
Area of Science:
- Immunology
- Human Genetics
- Aging Research
Background:
- Down's syndrome (DS) is associated with significant immunological defects, particularly affecting the T cell compartment.
- DS serves as a model for accelerated human aging, with observed thymic histological and morphological changes.
- Previous research lacked data on the thymus's T cell generation capacity in DS.
Purpose of the Study:
- To investigate the thymus's capacity to produce and release recent thymic emigrants (RTE) in children with Down's syndrome.
- To quantify T cell production using novel real-time PCR technology to measure TREC levels.
Main Methods:
- Studied 8 children with DS (aged 2-7 years) and 8 age/sex-matched healthy controls.
- Employed flow cytometry for lymphocyte subset analysis.
- Utilized real-time PCR (Taqman system) to quantify peripheral blood lymphocytes expressing T cell receptor rearrangement excision circles (TREC) as a measure of RTE.
Main Results:
- Children with DS exhibited significantly lower numbers of TREC+ peripheral blood cells compared to controls.
- A strong negative correlation between age and TREC+ cell levels was observed exclusively in children with DS.
- This indicates a reduced thymic output of newly generated T cells in DS.
Conclusions:
- Direct measurement of thymic output confirms impaired T cell production in Down's syndrome.
- The findings suggest that cytokines, such as interleukins, could potentially enhance thymic function.
- Therapeutic strategies targeting thymic function may help address immunodeficiency in DS subjects.